A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Clinical trial NCT06299748 · RECRUITING
Trial details
- NCT number
- NCT06299748
- Sponsor
- argenx
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-30
- Primary completion
- 2033-01-01
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.